1. Ask the Experts

2. This program will include a discussion of off-label treatments and investigational agents not approved by the FDA for use in the US. These data should be considered preliminary until published in a peer-reviewed journal.

3. EoE Overview

4. Epidemiology of EoE

5. Symptoms of EoE Children

6. Clinical Symptoms of EoE Adolescents and Adults

7. Diagnosis of EoE Is Challenging

8. Endoscopic Findings

9. The PPI Diagnostic Dilemma

10. The PPI Diagnostic Dilemma (cont)

11. Treatment Goals

12. Treatment Options for EoE

13. PPI Therapy

14. Steroids for EoE Overview

15. Swallowed Topical Steroids

16. Optimal Delivery of Topical Steroids

17. Budesonide Nebulized vs Viscous Oral Formulations

18. Budesonide Oral Suspension Phase 2 Trial

19. Budesonide Orodispersible Tablet Phase 3 Trial

20. Fluticasone Dissolvable Tablet Phase 1/2A Study

21. Elemental Diet

22. Elimination and Allergy-Directed Diets

23. Step-Up/Step-Down Elimination Diets

24. Elimination Diet Patient Education

25. IL-5 Inhibitors

26. Dupilumab Phase 2 Study

27. Anti-IL-13 RPC4046 Phase 2 Study

28. Endoscopic Dilation Therapy

29. Endoscopic Dilation Therapy (cont)

30. Endoscopic Dilation Images

31. Concluding Remarks

32. Abbreviations